U.S.-based medical technology manufacturer Medtronic has agreed to acquire orthopedic device provider China Kanghui Holdings for a net transaction value of US$755 million. China Kanghui Holdings is backed by private equity investors IDG Capital Partners, TDF Capital, CDH Investments and Vivo Ventures, all of which will reportedly sell their stakes to Medtronic as part of the transaction.